| # | Title | Journal | Year | Citations |
|---|
| 1 | Idiopathic intracranial hypertension: consensus guidelines on management | Journal of Neurology, Neurosurgery and Psychiatry | 2018 | 303 |
| 2 | Diagnosis and management of migraine in ten steps | Nature Reviews Neurology | 2021 | 194 |
| 3 | European headache federation consensus on the definition of resistant and refractory migraine | Journal of Headache and Pain | 2020 | 126 |
| 4 | European Headache Federation guideline on idiopathic intracranial hypertension | Journal of Headache and Pain | 2018 | 111 |
| 5 | Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom | JAMA Neurology | 2019 | 79 |
| 6 | Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial | Cephalalgia | 2019 | 69 |
| 7 | Advances in the understanding of headache in idiopathic intracranial hypertension | Current Opinion in Neurology | 2019 | 61 |
| 8 | Topiramate is more effective than acetazolamide at lowering intracranial pressure | Cephalalgia | 2019 | 58 |
| 9 | Botulinum toxins for the prevention of migraine in adults | The Cochrane Library | 2018 | 53 |
| 10 | Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain? | Cephalalgia | 2019 | 51 |
| 11 | Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension | JAMA Ophthalmology | 2020 | 43 |
| 12 | <p>Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting</p> | Eye and Brain | 2020 | 40 |
| 13 | Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis | Journal of Headache and Pain | 2021 | 40 |
| 14 | Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance | Journal of Headache and Pain | 2021 | 39 |
| 15 | Evaluation and management of adult idiopathic intracranial hypertension | Practical Neurology | 2018 | 38 |
| 16 | Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey | BMJ Open | 2018 | 37 |
| 17 | Idiopathic Intracranial Hypertension: Evaluation of Admissions and Emergency Readmissions through the Hospital Episode Statistic Dataset between 2002–2020 | Life | 2021 | 37 |
| 18 | Headache attributed to idiopathic intracranial hypertension and persistent post‐idiopathic intracranial hypertension headache: A narrative review | Headache | 2021 | 37 |
| 19 | European Headache Federation recommendations for neurologists managing giant cell arteritis | Journal of Headache and Pain | 2020 | 31 |
| 20 | Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation | Headache | 2021 | 31 |
| 21 | Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension | Journal of Neurology, Neurosurgery and Psychiatry | 2021 | 28 |
| 22 | Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension | Current Opinion in Neurology | 2019 | 27 |
| 23 | Emerging themes in idiopathic intracranial hypertension | Journal of Neurology | 2020 | 27 |
| 24 | Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure | Brain Communications | 2021 | 26 |
| 25 | Reviewing the Recent Developments in Idiopathic Intracranial Hypertension | Ophthalmology and Therapy | 2020 | 25 |
| 26 | Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension | Journal of Headache and Pain | 2020 | 24 |
| 27 | New horizons for idiopathic intracranial hypertension: advances and challenges | British Medical Bulletin | 2020 | 23 |
| 28 | Green Flags and headache: A concept study using the Delphi method | Headache | 2021 | 19 |
| 29 | Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT) | Journal of Neurology | 2022 | 17 |
| 30 | The Role of Metabolism in Migraine Pathophysiology and Susceptibility | Life | 2021 | 14 |
| 31 | Differing presenting features of idiopathic intracranial hypertension in the UK and US | Eye | 2019 | 11 |
| 32 | Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension | European Journal of Endocrinology | 2022 | 11 |
| 33 | Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema | Life | 2021 | 10 |
| 34 | Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension | Eye | 2020 | 9 |
| 35 | Optical coherence tomography confirms shunt malfunction and recurrence of raised intracranial pressure in optic atrophy | British Journal of Neurosurgery | 2022 | 6 |
| 36 | Telemetric monitoring in idiopathic intracranial hypertension demonstrates intracranial pressure in a case with sight-threatening disease | Acta Neurochirurgica | 2021 | 6 |
| 37 | Tip of the iceberg in idiopathic intracranial hypertension | Practical Neurology | 2019 | 5 |
| 38 | Practice points for ophthalmologists from the 2020 British Society for Rheumatology Giant Cell Arteritis guidelines | Eye | 2021 | 5 |
| 39 | Alterations in metabolic flux in migraine and the translational relevance | Journal of Headache and Pain | 2022 | 5 |
| 40 | WED 094 Diagnostic error rates in diagnosing idiopathic intracranial hypertension | Journal of Neurology, Neurosurgery and Psychiatry | 2018 | 0 |
| 41 | United Kingdom CSF Disorders Day 2018 | Neuro-Ophthalmology | 2019 | 0 |
| 42 | Response to ‘Comment on: ‘A new era for giant cell arteritis’’ | Eye | 2020 | 0 |
| 43 | 210 Erenumab for the treatment of chronic migraine with idiopathic intracranial hypertension in ocular remission | Journal of Neurology, Neurosurgery and Psychiatry | 2022 | 0 |
| 44 | 060 Calcitonin gene-related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension | Journal of Neurology, Neurosurgery and Psychiatry | 2022 | 0 |
| 45 | 053 Intracranial pressure determines headache morbidity in idiopathic intracranial hypertension | Journal of Neurology, Neurosurgery and Psychiatry | 2022 | 0 |
| 46 | 052 How much weight loss is required to reduce intracranial pressure in idiopathic intracranial hypertension? | Journal of Neurology, Neurosurgery and Psychiatry | 2022 | 0 |
| 47 | 077 Opiate and headache prescribing patterns in idiopathic intracranial hyperten- sion: a matched controlled retrospective cohort study | Journal of Neurology, Neurosurgery and Psychiatry | 2022 | 0 |
| 48 | 076 Iatrogenic spinal haematoma post lumbar puncture: A case report and literature review | Journal of Neurology, Neurosurgery and Psychiatry | 2022 | 0 |
